查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930097

注射生理食盐水市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察，2026-2034 年

Normal Saline for Parenteral Use Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 118 Pages | 商品交期: 请询问到货日

价格

注射生理食盐水市场成长驱动因子

全球注射生理食盐水市场正经历稳定成长，这主要得益于医院对输液的需求不断增加，这些输液用于治疗脱水、电解质失衡、败血症、出血和伤口护理等疾病。根据 Fortune Business Insights 预测，2025 年该市场规模预计将达到 39.1 亿美元，2026 年增长至 41.7 亿美元，并最终在 2034 年达到 71.5 亿美元。这意味着 2026 年至 2034 年的复合年增长率 (CAGR) 为 6.97%。预计到 2025 年，北美将以 39.46% 的市占率引领市场，这主要归功于 0.9% 氯化钠溶液的高普及率以及主要厂商在扩大产能方面的策略投资。 生理食盐水（0.9% 氯化钠溶液）是最常用的晶体溶液之一，并被 "倖存败血症运动" (SSC) 推荐用于败血症休剋期间的液体復苏。全球新生儿败血症发生率的不断上升（每年每 1000 例活产婴儿中诊断出 1-50 例）进一步推动了对生理食盐水的需求。住院人数上升、人口老化以及政府指南建议在重症监护中使用生理食盐水也是促成因素。

新冠疫情的影响

由于择期手术延迟和住院人数减少，新冠疫情暂时对市场成长造成了负面影响。在疫情高峰期，全球超过2,800万例择期手术被取消，ICU Med等机构报告称，2020年上半年静脉输液收入下降了10.3%。儘管面临这些不利因素，但由于疫情后的復苏和对医疗基础设施的日益重视，市场正在恢復成长。

市场趋势

流感季期间，尤其是H3N2等严重病毒株流行时，对生理食盐水的需求激增。例如，欧盟每年报告的流感感染病例高达 5,000 万例，促使住院人数增加，生理食盐水的使用量也随之上升。同样，美国在 2018-2019 年流感季期间的住院人数为 490,561 人。这些趋势凸显了生理食盐水在病人补液和药物输注方面发挥的关键作用。

市场成长因素

1. 重症监护领域使用量增加：生理食盐水对于治疗脱水、呕吐和腹泻，以及在加护病房 (ICU) 和新生儿加护病房 (NICU) 进行液体疗法至关重要。美国每年售出约 2 亿公升生理食盐水，全球每天使用量超过 100 万公升。

2.住院和手术数量增加：住院和手术数量的增加进一步推动了需求，因为静脉输液是医院护理的标准组成部分。例如，英国国家医疗服务体系 (NHS) 报告称，每年有超过 500 万例急性住院病例，其中许多病例需要静脉输註生理食盐水。

3. 政府指南：欧洲重症医学会 (ESICM) 等机构的建议支持在重症监护中广泛使用生理盐水，从而推动了市场渗透。

限制因子

由于转向使用平衡电解质输液，市场正面临挑战。研究表明，与生理食盐水相比，平衡电解质输液可降低死亡率和肾损伤，从而影响医院的采用。例如，范德比尔特大学的一项研究表明，每 100 名接受平衡电解质输液的患者中，死亡或严重肾臟併发症的发生率降低 1 例。

市场区隔

按类型

  • 塑胶瓶：由于其不易破损且易于分销，预计到 2026 年将成为领先细分市场，占 89.33% 的市场占有率。
  • 玻璃瓶：由于其污染风险低且具有环保优势，玻璃瓶预计将保持稳定成长。

按应用

  • 静脉输液：占最大的市占率（截至 2026 年为 97.45%）。这是因为静脉输液是最常用的给药途径。
  • 肌肉注射：由于其给药方便且创伤小，预计肌肉注射将保持稳定增长。

依地区划分

  • 北美：最大的市场，预计2025年将达到15.4亿美元，2026年将达到16.5亿美元。美国预计2026年将达15.7亿美元。
  • 亚太地区：由于住院人数增加、老年人口增长以及败血症盛行率上升，预计将显着增长。预计到2026年，日本将达到7亿美元，中国和印度将分别达到8,000万美元。
  • 欧洲：在政府支持和鼓励的推动下，预计到2026年，英国将达到8,000万美元，德国将达到1.1亿美元。
  • 世界其他地区：由于医疗基础设施的改善，预计拉丁美洲以及中东和非洲将实现温和成长。

主要参与者

推动市场发展的主要参与者包括百特（美国）、科伦集团（中国）、贝朗医疗（德国）、费森尤斯卡比（德国）和ICU Medical（美国）。这些公司专注于研发、策略合作和产能扩张。例如，2022年8月，Assure Infusions宣布在佛罗里达州建造一座全自动静脉输液工厂，以满足美国市场的高需求。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇

第四章：关键考虑因素

  • 主要国家及地区住院病患人数（2025年）
  • 主要国家和地区主要疾病盛行率（2025年）
  • 关键产业趋势－併购与合作
  • 新冠疫情对市场的影响

第五章：全球静脉输液市场分析、洞察与预测 2021-2034

  • 市场分析、洞察与预测 - 按类型划分
    • 塑胶瓶
    • 玻璃瓶
  • 市场分析、洞察与预测 - 按应用划分
    • 肌肉注射
    • 静脉注射
  • 市场分析、洞察与预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美注射生理食盐水市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国各州
    • 加拿大

第7章 欧洲的注射用生理食盐水市场分析，洞察与预测，2021～2034年

第8章 亚太地区的注射用生理食盐水市场分析，洞察与预测，2021～2034年

第9章 南美的注射用生理食盐水市场分析，洞察与预测(2021～2034年)

第10章 中东·非洲的注射用生理食盐水市场分析，洞察与预测，2021～2034年

第11章 竞争分析

  • 全球市场占有率分析(2025年)
  • 企业简介
    • Baxter
    • Kelun Group
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • SSY Group Limited
    • ICU Medical
    • Double-Crane Pharmaceutical Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • Cisen Pharmaceutical Co., Ltd.
    • Pharmally International Holding Co., Ltd.
    • 其他的主要企业
Product Code: FBI104520

Growth Factors of normal saline for parenteral use Market

The global normal saline for parenteral use market is witnessing steady growth, driven by the increasing demand for intravenous fluids in hospitals for conditions such as dehydration, electrolyte imbalance, sepsis, hemorrhage, and wound dressing. According to Fortune Business Insights, the market was valued at USD 3.91 billion in 2025 and is projected to grow to USD 4.17 billion in 2026, ultimately reaching USD 7.15 billion by 2034, reflecting a CAGR of 6.97% during 2026-2034. North America dominated the market in 2025 with a 39.46% share, largely due to the high uptake of 0.9% sodium chloride solutions and strategic investments by key players to expand production capacity.

Normal saline (0.9% sodium chloride) is one of the most commonly used crystalloid fluids, particularly recommended by the Surviving Sepsis Campaign (SSC) for fluid resuscitation in septic shock. The rising incidence of neonatal sepsis globally-diagnosed in 1 to 50 per 1,000 live births annually-further boosts demand for normal saline. Increasing hospital admissions, geriatric populations, and government guidelines recommending saline in critical care are additional growth drivers.

COVID-19 Impact

The COVID-19 pandemic had a temporary negative impact on market growth due to postponed elective surgeries and reduced hospital admissions. Over 28 million elective surgeries were canceled globally during the peak disruption, and organizations like ICU Med reported a 10.3% revenue decrease for IV solutions in the first half of 2020. Despite this setback, post-pandemic recovery and an increased focus on healthcare infrastructure have allowed the market to resume its growth trajectory.

Market Trends

Demand for normal saline spikes during flu seasons, particularly with severe strains such as H3N2. For example, the European Union reported up to 50 million influenza infections annually, driving hospitalizations and saline use. Similarly, the U.S. experienced 490,561 hospital admissions during the 2018-2019 flu season. These trends highlight the critical role of normal saline in patient hydration and medication delivery.

Market Growth Factors

1. Rising Use in Critical Care: Saline is essential for managing dehydration, vomiting, diarrhea, and fluid resuscitation in ICU and NICU settings. Approximately 200 million liters of saline are sold annually in the U.S., while over 1 million liters are administered globally each day.

2. Hospital Admissions and Surgeries: Growing numbers of in-patients and surgical procedures further fuel demand, as intravenous therapy is a standard component of hospital care. For instance, the NHS reports over 5 million acute hospital admissions annually, many requiring IV saline.

3. Government Guidelines: Recommendations from bodies such as the European Society of Intensive Care Medicine (ESICM) support the widespread use of saline in critical care, strengthening market adoption.

Restraining Factors

The market faces challenges due to the shift toward balanced IV fluids. Studies indicate that balanced solutions reduce mortality and kidney damage compared to normal saline, influencing hospital adoption. For example, a Vanderbilt University study found one fewer death or severe kidney complication per 100 patients administered balanced fluids.

Market Segmentation

By Type:

  • Plastic Bottles: Dominant segment, expected to hold 89.33% of the market in 2026, due to breakage prevention and easier distribution.
  • Glass Bottles: Offers lower contamination risk and environmental benefits; projected to grow steadily.

By Application:

  • Intravenous Injection: Largest share (97.45% in 2026) due to being the preferred administration route.
  • Intramuscular Injection: Expected to grow steadily due to ease of administration and low invasiveness.

By Region:

  • North America: Largest market, USD 1.54 billion in 2025, rising to USD 1.65 billion in 2026, with the U.S. projected at USD 1.57 billion in 2026.
  • Asia Pacific: Significant growth due to rising hospital admissions, geriatric population, and sepsis prevalence; Japan at USD 0.7 billion, China and India at USD 0.08 billion each in 2026.
  • Europe: Driven by government support and recommendations; UK at USD 0.08 billion, Germany at USD 0.11 billion in 2026.
  • Rest of the World: Moderate growth in Latin America and Middle East & Africa due to improving healthcare infrastructure.

Key Players

Major companies shaping the market include Baxter (U.S.), Kelun Group (China), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), ICU Medical (U.S.), among others. These firms focus on R&D, strategic collaborations, and production capacity expansion. For example, in August 2022, Assure Infusions announced a fully automated IV fluids plant in Florida to meet high U.S. demand.

Conclusion

The global normal saline for parenteral use market is set for consistent growth, expanding from USD 3.91 billion in 2025 to USD 7.15 billion by 2034, driven by increasing hospitalizations, surgical procedures, sepsis incidence, and supportive government guidelines. Despite challenges from the shift to balanced fluids, innovations in packaging, distribution, and production capacity, along with rising demand across North America, Europe, and Asia Pacific, are expected to sustain market growth and ensure the widespread availability of saline for critical care applications globally.

Segmentation By Type

  • Plastic Bottles
  • Glass Bottles

By Application

  • Intramuscular injection
  • Intravenous injection

By Geography

  • North America (By Type, Application, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, and Country)
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific (By Type, Application, and Country)
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Rest of the Asia Pacific
  • Latin America (By Type, Application, and Country)
    • Mexico
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, and Country)
    • Turkey
    • Saudi Arabia
    • UAE
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Number of Hospital Admissions, By Key Countries/Regions, 2025
  • 4.2. Prevalence of Key Diseases, By Key Countries/Regions, 2025
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of COVID-19 on the Market

5. Global Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Plastic Bottles
    • 5.1.2. Glass Bottles
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Intramuscular Injection
    • 5.2.2. Intravenous Injection
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Plastic Bottles
    • 6.1.2. Glass Bottles
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Intramuscular Injection
    • 6.2.2. Intravenous Injection
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Plastic Bottles
    • 7.1.2. Glass Bottles
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Intramuscular Injection
    • 7.2.2. Intravenous Injection
  • 7.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Russia
    • 7.3.6. Rest of Europe

8. Asia Pacific Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Plastic Bottles
    • 8.1.2. Glass Bottles
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Intramuscular Injection
    • 8.2.2. Intravenous Injection
  • 8.3. Market Analysis, Insights and Forecast - By Countries/ Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. South Korea
    • 8.3.6. Taiwan
    • 8.3.7. Indonesia
    • 8.3.8. Thailand
    • 8.3.9. Malaysia
    • 8.3.10. Rest of Asia Pacific

9. Latin America Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Plastic Bottles
    • 9.1.2. Glass Bottles
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Intramuscular Injection
    • 9.2.2. Intravenous Injection
  • 9.3. Market Analysis, Insights and Forecast - By Countries/ Sub regions
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Colombia
    • 9.3.4. Argentina
    • 9.3.5. Rest of Latin America

10. Middle East & Africa Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Plastic Bottles
    • 10.1.2. Glass Bottles
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Intramuscular Injection
    • 10.2.2. Intravenous Injection
  • 10.3. Market Analysis, Insights and Forecast - By Countries/ Sub region
    • 10.3.1. Turkey
    • 10.3.2. Saudi Arabia
    • 10.3.3. UAE
    • 10.3.4. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Baxter
      • 11.2.1.1. Overview
      • 11.2.1.2. Product
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Kelun Group
      • 11.2.2.1. Overview
      • 11.2.2.2. Product
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. B. Braun Melsungen AG
      • 11.2.3.1. Overview
      • 11.2.3.2. Product
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Fresenius Kabi AG
      • 11.2.4.1. Overview
      • 11.2.4.2. Product
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. SSY Group Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Product
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. ICU Medical
      • 11.2.6.1. Overview
      • 11.2.6.2. Product
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Double-Crane Pharmaceutical Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Product
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Otsuka Pharmaceutical Co., Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Product
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Cisen Pharmaceutical Co., Ltd.
      • 11.2.9.1. Overview
      • 11.2.9.2. Product
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)
    • 11.2.10. Pharmally International Holding Co., Ltd.
      • 11.2.10.1. Overview
      • 11.2.10.2. Product
      • 11.2.10.3. SWOT analysis
      • 11.2.10.4. Recent developments
      • 11.2.10.5. strategies
      • 11.2.10.6. financials (based on availability)
    • 11.2.11. Other Prominent Players

List of Tables

  • Table 01: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 02: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 03: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 04: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 05: Global Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 06: Global Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Region, 2021-2034
  • Table 07: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 08: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 09: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 10: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 11: North America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 12: North America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country, 2021-2034
  • Table 13: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 15: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 17: Europe Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 18: Europe Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 21: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 24: Asia Pacific Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 25: Latin America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 27: Latin America Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 29: Latin America Normal Saline for Parenteral Use Market Revenue (USD million) Forecast, by Country/Sub-region, 2021-2034
  • Table 30: Latin America Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034
  • Table 31: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Type, 2021-2034
  • Table 33: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Country/Sub-region, 2021-2034
  • Table 36: Middle East & Africa Normal Saline for Parenteral Use Market Volume (million liters) Forecast, by Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Normal Saline for Parenteral Use Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 02: Global Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025 & 2034
  • Figure 03: Global Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025 & 2034
  • Figure 04: Global Normal Saline for Parenteral Use Market Value Share (%), by Region, 2025 & 2034
  • Figure 05: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 06: North America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 07: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 08: North America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 09: North America Normal Saline for Parenteral Use Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 10: North America Normal Saline for Parenteral Use Market Value Share (%), by Country, 2025
  • Figure 11: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 12: Europe Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 13: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 14: Europe Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 15: Europe Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 16: Europe Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 17: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 23: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 24: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 26: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 27: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025 & 2034
  • Figure 28: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025 & 2034
  • Figure 29: Latin America Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 30: Latin America Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 31: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Type, 2025 & 2034
  • Figure 32: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Type, 2025
  • Figure 33: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Application, 2025 & 2034
  • Figure 34: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Application, 2025
  • Figure 35: Middle East & Africa Normal Saline for Parenteral Use Market Value (USD Billion), by Country/Sub-region, 2025 & 2034
  • Figure 36: Middle East & Africa Normal Saline for Parenteral Use Market Value Share (%), by Country/Sub-region, 2025
  • Figure 37: Global Normal Saline for Parenteral Use Market Share Analysis (%), By Company, 2025